Search research articles
Contact Us
Filters
Showing results (141-150 of 339) with videos related to
Page
of 34
Sort By:
Medical Oncology (Northwood, London, England)
|
June 26, 2012
Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17)
Peter H Wiernik, Zhuoxin Sun, Holly Gundacker, et al.
The Lancet. Haematology
|
July 5, 2016
Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial
Colleen Delaney, Filippo Milano, Laura Cicconi, et al.
British Journal of Haematology
|
May 27, 2015
Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid
Keith R Loeb, Sindhu Cherian, Pamela S Becker, et al.
Leukemia & Lymphoma
|
March 30, 2017
Flow cytometric demonstration of decrease in bone marrow leukemic blasts after 'Day 14' without further therapy in acute myeloid leukemia
Xueyan Chen, Megan Othus, Brent L Wood, et al.
Transplantation and Cellular Therapy
|
June 24, 2024
Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Adult Acute Myeloid Leukemia: Outcomes and Prognostic Factors
Eduardo Rodríguez-Arbolí, Megan Othus, Corentin Orvain, et al.
American Journal of Hematology
|
February 21, 2024
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML
Corentin Orvain, Naveed Ali, Megan Othus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 30, 2005
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia
Daniella M B Kerbauy, Faith Chyou, Ted Gooley, et al.
American Journal of Hematology
|
August 19, 2007
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500)
Stephen H Petersdorf, Cathryn Rankin, David R Head, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 28, 2014
Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods
Wael Saber, Jennifer Le Rademacher, Mikkael Sekeres, et al.
Leukemia
|
April 20, 2022
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
Lucas C Zarling, Megan Othus, Brenda M Sandmaier, et al.
Page
of 34
Search research articles
Search
Showing results (141-150 of 339) with videos related to
Sort By:
Page
of 34
Medical Oncology (Northwood, London, England)
|
June 26, 2012
Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17)
Peter H Wiernik, Zhuoxin Sun, Holly Gundacker, et al.
The Lancet. Haematology
|
July 5, 2016
Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial
Colleen Delaney, Filippo Milano, Laura Cicconi, et al.
British Journal of Haematology
|
May 27, 2015
Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid
Keith R Loeb, Sindhu Cherian, Pamela S Becker, et al.
Leukemia & Lymphoma
|
March 30, 2017
Flow cytometric demonstration of decrease in bone marrow leukemic blasts after 'Day 14' without further therapy in acute myeloid leukemia
Xueyan Chen, Megan Othus, Brent L Wood, et al.
Transplantation and Cellular Therapy
|
June 24, 2024
Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Adult Acute Myeloid Leukemia: Outcomes and Prognostic Factors
Eduardo Rodríguez-Arbolí, Megan Othus, Corentin Orvain, et al.
American Journal of Hematology
|
February 21, 2024
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML
Corentin Orvain, Naveed Ali, Megan Othus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 30, 2005
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia
Daniella M B Kerbauy, Faith Chyou, Ted Gooley, et al.
American Journal of Hematology
|
August 19, 2007
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500)
Stephen H Petersdorf, Cathryn Rankin, David R Head, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 28, 2014
Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods
Wael Saber, Jennifer Le Rademacher, Mikkael Sekeres, et al.
Leukemia
|
April 20, 2022
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
Lucas C Zarling, Megan Othus, Brenda M Sandmaier, et al.
Page
of 34